
Faculty, Staff and Student Publications
Publication Date
1-1-2024
Journal
Epilepsy & Behavior Reports
Abstract
Anhedonia is clinically defined as difficulty or inability to feel pleasure or to be motivated to perform activities that were previously pleasurable. Anhedonia is a core feature of depressive disorders but can be present in other conditions such as substance use and anxiety disorders. Herein we report the case of a 34-year-old female who developed marked anhedonia after left cortico-amygdalohippocampectomy. Despite optimal seizure control, the person struggled with anhedonia and other depressive symptoms. After ruling out medico-neurologic complications, she was prescribed with a selective serotonin reuptake inhibitor and cognitive-behavioral therapy. Anhedonia can be a challenging neuropsychiatric presentation that requires ruling out the effects of antiseizure medications, neurosurgery, and other drugs before prescribing antidepressants.
Keywords
Anhedonia, Depression, Epilepsy Surgery, Selective Serotonin Reuptake Inhibitor, Temporal Lobe Epilepsy
DOI
10.1016/j.ebr.2024.100658
PMID
38495401
PMCID
PMC10940138
PubMedCentral® Posted Date
March 2024
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes
Included in
Bioinformatics Commons, Biomedical Informatics Commons, Neurology Commons, Neurosciences Commons, Oncology Commons
Comments
PMID: 38495401